TruScreen Group Limited (TRU.AX)
- Previous Close
0.0160 - Open
0.0180 - Bid 0.0180 x 51000
- Ask 0.0210 x 4523900
- Day's Range
0.0180 - 0.0190 - 52 Week Range
0.0160 - 0.0350 - Volume
138,540 - Avg. Volume
84,137 - Market Cap (intraday)
9.591M - Beta (5Y Monthly) -0.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.75
Truscreen Group Limited, together with its subsidiaries, engages in the development, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
truscreen.comRelated News
Performance Overview: TRU.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TRU.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TRU.AX
Valuation Measures
Market Cap
7.46M
Enterprise Value
6.72M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.66
Price/Book (mrq)
7.45
Enterprise Value/Revenue
4.04
Enterprise Value/EBITDA
-2.29
Financial Highlights
Profitability and Income Statement
Profit Margin
-113.99%
Return on Assets (ttm)
-58.47%
Return on Equity (ttm)
-144.54%
Revenue (ttm)
2.23M
Net Income Avi to Common (ttm)
-2.54M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
807.23k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.24M
Research Analysis: TRU.AX
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: TRU.AX
TRU.AX does not have Company Insights